Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / HOWL - Werewolf Therapeutics: Continuing To Advance And Show More Promise In Phase 1

HOWL - Werewolf Therapeutics: Continuing To Advance And Show More Promise In Phase 1

Werewolf Therapeutics Inc.

2024-07-01 10:04:30 ET

Summary

  • Werewolf Therapeutics, Inc. is an early-stage biotech focusing on cytokine therapy for cancer treatment.
  • The Pipeline update includes positive results for WTX-124 in clinical trials and promising data for WTX-330.
  • Financially, the company has a decent cash position for now, but may need to address cash burn rate in the near future.

Topline Summary and Update

For further details see:

Werewolf Therapeutics: Continuing To Advance And Show More Promise In Phase 1
Stock Information
Company Name: Werewolf Therapeutics Inc.
Stock Symbol: HOWL
Market: NASDAQ
Website: werewolftx.com
Menu
HOWL HOWL Quote HOWL Short HOWL News HOWL Articles HOWL Message Board
Get HOWL Alerts

News, Short Squeeze, Breakout and More Instantly...